TY - JOUR AU - Gu, L. AU - Gonzalez, F. J. AU - Kalow, W. AU - Tang, B. K. PY - 1992 DA - 1992// TI - Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1 JO - Pharmacogenetics VL - 2 UR - https://doi.org/10.1097/00008571-199204000-00004 DO - 10.1097/00008571-199204000-00004 ID - Gu1992 ER - TY - JOUR AU - Faber, M. S. AU - Jetter, A. AU - Fuhr, U. PY - 2005 DA - 2005// TI - Assessment of CYP1A2 activity in clinical practice: why, how, and when? JO - Basic Clin Pharmacol Toxicol VL - 97 UR - https://doi.org/10.1111/j.1742-7843.2005.pto_973160.x DO - 10.1111/j.1742-7843.2005.pto_973160.x ID - Faber2005 ER - TY - JOUR AU - Schrenk, D. AU - Brockmeier, D. AU - Mörike, K. AU - Bock, K. W. AU - Eichelbaum, M. PY - 1998 DA - 1998// TI - A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers JO - Eur J Clin Pharmacol VL - 53 UR - https://doi.org/10.1007/s002280050394 DO - 10.1007/s002280050394 ID - Schrenk1998 ER - TY - JOUR AU - Tantcheva-Poór, I. AU - Zaigler, M. AU - Rietbrock, S. AU - Fuhr, U. PY - 1999 DA - 1999// TI - Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test JO - Pharmacogenetics VL - 9 ID - Tantcheva-Poór1999 ER - TY - JOUR AU - Barnett, C. R. AU - Wilson, J. AU - Wolf, C. R. AU - Flatt, P. R. AU - Ioannides, C. PY - 1992 DA - 1992// TI - Hyperinsulinemia causes a preferential increase in hepatic P4501A2 activity JO - Biochem Pharmacol VL - 43 UR - https://doi.org/10.1016/0006-2952(92)90500-I DO - 10.1016/0006-2952(92)90500-I ID - Barnett1992 ER - TY - JOUR AU - Hong, C. C. AU - Tang, B. K. AU - Hammond, G. L. AU - Tritchler, D. AU - Yaffe, M. AU - Boyd, N. F. PY - 2004 DA - 2004// TI - Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr798 DO - 10.1186/bcr798 ID - Hong2004 ER - TY - JOUR AU - Sachse, C. AU - Bhambra, U. AU - Smith, G. AU - Lightfoot, T. J. AU - Barrett, J. H. AU - Scollay, J. AU - Garner, R. C. AU - Boobis, A. R. AU - Wolf, C. R. AU - Gooderham, N. J. PY - 2003 DA - 2003// TI - Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism JO - Br J Clin Pharmacol VL - 55 UR - https://doi.org/10.1046/j.1365-2125.2003.01733.x DO - 10.1046/j.1365-2125.2003.01733.x ID - Sachse2003 ER - TY - JOUR AU - Sachse, C. AU - Brockmöller, J. AU - Bauer, S. AU - Roots, I. PY - 1999 DA - 1999// TI - Functional significance of a C to A polymorphism in intron 1 of the CYP1A2 gene tested with caffeine JO - Br J Clin Pharmacol VL - 47 UR - https://doi.org/10.1046/j.1365-2125.1999.00898.x DO - 10.1046/j.1365-2125.1999.00898.x ID - Sachse1999 ER - TY - JOUR AU - Fuhr, U. AU - Rost, K. L. AU - Engelhardt, R. PY - 1996 DA - 1996// TI - Evaluation of caffeine as a test drug for CYP1A2. NAT2 and CYP2E1 phenotyping in man in vivo versus in vitro correlations JO - Pharmacogenetics VL - 6 UR - https://doi.org/10.1097/00008571-199604000-00003 DO - 10.1097/00008571-199604000-00003 ID - Fuhr1996 ER - TY - JOUR AU - Streetman, D. S. AU - Bertino, J. S. AU - Nafziger, A. N. PY - 2000 DA - 2000// TI - Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes JO - Pharmacogenetics VL - 10 UR - https://doi.org/10.1097/00008571-200004000-00001 DO - 10.1097/00008571-200004000-00001 ID - Streetman2000 ER - TY - JOUR AU - Fuhr, U. AU - Rost, K. L. PY - 1994 DA - 1994// TI - Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and saliva JO - Pharmacogenetics VL - 4 UR - https://doi.org/10.1097/00008571-199406000-00001 DO - 10.1097/00008571-199406000-00001 ID - Fuhr1994 ER - TY - STD TI - Urry E, Jetter A, Holst SC, Berger W, Spinas GA, Langhans W, Landolt HP. Relationships among type 2 diabetes, sleepiness, and habitual caffeine intake: a case–control field study. J Psychopharmacol. 2016. In press. doi:10.1177/0269881116668595. ID - ref12 ER - TY - JOUR AU - Matzke, G. R. AU - Reginald, F. F. AU - John, J. E. AU - Robert, J. S. AU - Stanley, W. C. PY - 2000 DA - 2000// TI - Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity JO - Pharmacotherapy VL - 20 UR - https://doi.org/10.1592/phco.20.3.182.34775 DO - 10.1592/phco.20.3.182.34775 ID - Matzke2000 ER - TY - JOUR AU - Spigset, O. AU - Hägg, S. AU - Söderström, E. AU - Dahlqvist, R. PY - 1999 DA - 1999// TI - The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained? JO - Pharmacogenetics VL - 9 UR - https://doi.org/10.1097/00008571-199906000-00019 DO - 10.1097/00008571-199906000-00019 ID - Spigset1999 ER - TY - JOUR AU - Rétey, J. V. AU - Adam, M. AU - Khatami, R. PY - 2007 DA - 2007// TI - Genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep JO - Clin Pharmacol Ther VL - 81 UR - https://doi.org/10.1038/sj.clpt.6100102 DO - 10.1038/sj.clpt.6100102 ID - Rétey2007 ER - TY - JOUR AU - Han, X. M. AU - Ou-Yang, D. S. AU - Lu, P. X. PY - 2001 DA - 2001// TI - Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2 JO - Pharmacogenetics VL - 11 UR - https://doi.org/10.1097/00008571-200107000-00006 DO - 10.1097/00008571-200107000-00006 ID - Han2001 ER - TY - JOUR AU - Perera, V. AU - Gross, A. S. AU - McLachlan, A. J. PY - 2010 DA - 2010// TI - Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma JO - Biomed Chromatogr VL - 24 UR - https://doi.org/10.1002/bmc.1419 DO - 10.1002/bmc.1419 ID - Perera2010 ER - TY - JOUR AU - Perera, V. AU - Gross, A. S. AU - Xu, H. AU - McLachlan, A. J. PY - 2011 DA - 2011// TI - Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics JO - J Pharm Pharmacol VL - 63 UR - https://doi.org/10.1111/j.2042-7158.2011.01326.x DO - 10.1111/j.2042-7158.2011.01326.x ID - Perera2011 ER - TY - JOUR AU - Grant, D. M. AU - Tang, B. K. AU - Kalow, W. PY - 1983 DA - 1983// TI - Variability in caffeine metabolism JO - Clin Pharmacol Ther VL - 33 UR - https://doi.org/10.1038/clpt.1983.80 DO - 10.1038/clpt.1983.80 ID - Grant1983 ER - TY - JOUR AU - Kalow, W. AU - Tang, B. K. PY - 1993 DA - 1993// TI - The use of caffeine for enzyme assays: a critical appraisal JO - Clin Pharmacol Ther VL - 53 UR - https://doi.org/10.1038/clpt.1993.63 DO - 10.1038/clpt.1993.63 ID - Kalow1993 ER - TY - JOUR AU - Rostami-Hodjegan, A. AU - Nurminen, S. AU - Jackson, P. R. AU - Tucker, G. T. PY - 1996 DA - 1996// TI - Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment JO - Pharmacogenet VL - 6 UR - https://doi.org/10.1097/00008571-199604000-00001 DO - 10.1097/00008571-199604000-00001 ID - Rostami-Hodjegan1996 ER - TY - JOUR AU - Labedzki, A. AU - Buters, J. AU - Jabrane, W. AU - Fuhr, U. PY - 2002 DA - 2002// TI - Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2 JO - Biochem Pharmacol VL - 63 UR - https://doi.org/10.1016/S0006-2952(02)01019-5 DO - 10.1016/S0006-2952(02)01019-5 ID - Labedzki2002 ER - TY - BOOK AU - Field, A. PY - 2013 DA - 2013// TI - Discovering statistics using IBM SPSS statistics PB - Sage CY - London ID - Field2013 ER - TY - JOUR AU - Babyak, M. A. PY - 2004 DA - 2004// TI - What You See May Not Be What You Get: A Brief, Nontechnical Introduction to Overfitting in Regression-Type Models JO - Psychosom Med VL - 66 ID - Babyak2004 ER - TY - JOUR AU - Fredholm, B. B. AU - Bättig, K. AU - Holmén, J. AU - Nehlig, A. AU - Zvartau, E. E. PY - 1999 DA - 1999// TI - Actions of caffeine in the brain with special reference to factors that contribute to its widespread use JO - Pharmacol Rev VL - 51 ID - Fredholm1999 ER - TY - JOUR AU - Chen, L. AU - Bondoc, F. Y. AU - Lee, M. J. AU - Hussin, A. H. AU - Thomas, P. E. AU - Yang, C. S. PY - 1996 DA - 1996// TI - Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats JO - Drug Metab Dispos VL - 24 ID - Chen1996 ER - TY - JOUR AU - Goasduff, T. AU - Dréano, Y. AU - Guillois, B. AU - Menez, J. F. AU - Berthou, F. PY - 1996 DA - 1996// TI - Induction of liver and kidney CYP1A1/1A2 by caffeine in rat JO - Biochem Pharmacol VL - 52 UR - https://doi.org/10.1016/S0006-2952(96)00522-9 DO - 10.1016/S0006-2952(96)00522-9 ID - Goasduff1996 ER - TY - JOUR AU - Landi, M. T. AU - Zocchetti, C. AU - Bernucci, I. AU - Kadlubar, F. F. AU - Tannenbaum, S. AU - Skipper, P. AU - Bartsch, H. AU - Malaveille, C. AU - Shields, P. AU - Caporaso, N. E. AU - Vineis, P. PY - 1996 DA - 1996// TI - Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels JO - Cancer Epidemiol Biomarkers Prev VL - 5 ID - Landi1996 ER - TY - JOUR AU - Fontana, R. J. AU - Lown, K. S. AU - Paine, M. F. AU - Fortlage, L. AU - Santella, R. M. AU - Felton, J. S. AU - Knize, M. G. AU - Greenberg, A. AU - Watkins, P. B. PY - 1999 DA - 1999// TI - Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers JO - Gastroenterology VL - 117 UR - https://doi.org/10.1016/S0016-5085(99)70554-8 DO - 10.1016/S0016-5085(99)70554-8 ID - Fontana1999 ER - TY - JOUR AU - Palatini, P. AU - Benetti, E. AU - Mos, L. AU - Garavelli, G. AU - Mazzer, A. AU - Cozzio, S. AU - Fania, C. AU - Casiglia, E. PY - 2015 DA - 2015// TI - Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients JO - Eur J Epidemiol VL - 30 UR - https://doi.org/10.1007/s10654-015-9990-z DO - 10.1007/s10654-015-9990-z ID - Palatini2015 ER - TY - JOUR AU - Addicott, M. A. AU - Yang, L. L. AU - Peiffer, A. M. AU - Laurienti, P. J. PY - 2009 DA - 2009// TI - Methodological considerations for the quantification of self-reported caffeine use JO - Psychopharmacology VL - 203 UR - https://doi.org/10.1007/s00213-008-1403-5 DO - 10.1007/s00213-008-1403-5 ID - Addicott2009 ER - TY - JOUR AU - Bracken, M. B. AU - Triche, E. AU - Grosso, L. AU - Hellenbrand, K. AU - Belanger, K. AU - Leaderer, B. P. PY - 2002 DA - 2002// TI - Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects JO - Epidemiology VL - 13 UR - https://doi.org/10.1097/00001648-200203000-00011 DO - 10.1097/00001648-200203000-00011 ID - Bracken2002 ER -